Report description

Antibiotics are also known as anti-bacterials or antimicrobials. Since the discovery of the antibiotic penicillin in 1920 antibiotics are used in the treatment of infections caused by germs-bacteria and certain parasites-via inhibiting the growth of microorganisms or killing them. Certain factors that are driving the market growth include the emergence of anti-MRSA drugs, development of generic drugs, and vulnerable aging population. The global antibiotics market witness growth by the development of novel approaches for new antibiotics for treating bacterial infections and a large number of clinical trials also increase in incidence of infectious diseases such as HIV/AIDS, pneumonia, malaria, and tuberculosis, and the market scenario of demand and supply of antibiotics are the other factors propelling the market. The global antibiotics market size is $XXXX million in 2018, and is expected to forecast $ XXXX million by 2024, growing at a CAGR of 1.8% from 2018 to 2024.

A large number of players have been focusing on new drug development and clinical trials. Prominent biotechnology companies are entering into strategic alliances, which have helped them make considerable investments in drug discovery. Pharmaceutical companies are developing analogues of existing antibiotic classes based on innovative approaches to fight bacterial infections. Rising demand for antibiotics to counter increasing cases of drug-resistant infections, combined with decreasing Research and Development (R&D) costs, is presenting a suitable opportunity for pharmaceutical manufacturers to launch novel products into the marketplace. The increase in patient assistance programs (PAPs) on the usage and benefits related to antibiotics will be one of the major factors driving the global antibiotics market growth through 2024, These programs allow pharmaceutical companies to provide free samples or discounted medicines to low-income patients and uninsured and under-insured patients, thus driving antibiotics market demand.

In present the demand for beta lactam & beta lactamase inhibitors segment generated the highest revenue in 2017 and is anticipated to maintain its dominance throughout the forecast period. This is attributed to its broad-spectrum activity, which heals infections caused due to multiple groups of bacteria. Thus, the demand for beta lactam & beta lactamase inhibitors is high among the healthcare providers and patients, which in turn fuels the growth of the global antibiotics market.

Asia-Pacific represent the large share in the global market in the session of 2017, accounting for the highest share, and is predicted for maintaining the same trend in the upcoming forecast period of 2024. This is attributed to increased consumption of antibiotics, their easy availability, and rise in sale of over-the-counter drugs.

• Cephalosporin antibiotics market
• Penicillin antibiotics market
• Fluroquinilone antibiotics market
• Macrolide antibiotics market
• Carbapenem antibiotics market
• Aminoglycoside antibiotics market
• Sulfonamide antibiotics market

• Human antibiotics market
• Animal antibiotics market

• Beta-lactam antibiotics market
• Macrolide antibiotics market
• Quinolone antibiotics market

• Bacteriostatic antibiotics market
• Bactericidal antibiotics market

• Broad-spectrum antibiotics market
• Narrow-spectrum antibiotics market

Top Players in Global Antibiotic industry

• Abbott Laboratories
• GlaxoSmithKline Plc
• Allergan Plc.
• Mylan N.V.
• F.Hoffmann-La Roche Ltd.
• Pfizer Inc.
• Merck & Co. Inc.
• Novartis International AG (Sandoz)
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• Aurobindo Pharma
• Eli Lilly
• Lupin Pharmaceuticals
• Bayer HealthCare
• Sun Pharmaceutical
• Shionogi

The report includes complete evaluation of the market via in-depth quantitative & qualitative insights, secondary & primary verification, historical data, and market size & forecast. The projections in this report are based on various methodologies & assumption.